Over-the-counter drug · ANDA
Morning After Pill (levonorgestrel) NDC 73436-2859
Levonorgestrel 1.5 mg/1 · Tablet · Oral · Cadence Health Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73436-2859-1 | 73436285901 | 1 BLISTER PACK in 1 CARTON (73436-2859-1) / 1 TABLET in 1 BLISTER PACKMarketed from Oct 1, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Morning After Pill
- Generic name (nonproprietary)
- levonorgestrel
- Active ingredients
- Levonorgestrel — 1.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Cadence Health Inc
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202380
- Marketing start
- Listing expires
- Other FDA classes
- Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 73436-2859_2e251776-063e-0e05-e063-6294a90a8e98SPL ID 2e251776-063e-0e05-e063-6294a90a8e98SPL set ID fc5d29bb-4a4b-e61e-e053-6394a90a8a62RxCUI 483325, 1657617UNII 5W7SIA7YZW
- Pharmacologic class
- Progestin; Progestin-containing Intrauterine System
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473436285901followed by a unit qualifier and the quantityPackage 73436-2859-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202380
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Levonorgestrel Tablet, 1.5 mg | Levonorgestrel 1.5 mg/1 | TabletOral | Strides Pharma Inc | 59556-282 |
| Optionellelevonorgestrel tablet, 1.5 mg | Levonorgestrel 1.5 mg/1 | TabletOral | Strides Pharma Inc | 59556-286 |